Patents by Inventor Roger D. Griggs

Roger D. Griggs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7062312
    Abstract: A method and combination including a visual marker for monitoring a patient to determine compliance with a medication regimen. An orally administrable medication composition is provided in combination with a visual marker. When the combination is orally ingested, the marker causes a coloration or discoloration of the oral and/or pharyngeal cavity of a subject. By visually observing the oral and/or pharyngeal cavity of the subject, one can determine whether medication has been ingested based upon the presence or absence of the coloration/discoloration.
    Type: Grant
    Filed: January 17, 2001
    Date of Patent: June 13, 2006
    Assignee: PediaMed Pharmaceuticals, Inc.
    Inventors: Gilbert R. Gonzales, Roger D. Griggs
  • Patent number: 6687050
    Abstract: An amplifying module 101 for an optical network has a fiber amplifier 102 for amplifying a multiplexed optical stream having a plurality of wavelength channels. The fiber amplifier 102 has a set point gain. The module 101 has module control means 108 for controlling the operating conditions of the fiber amplifier 102 and supplying means for supplying to the module control means 108 information representative of the channel loading condition. In response to the information, the module control means 108 adjusts the operating conditions of the fiber amplifier 102 such that the fiber amplifier gain does not exceed an acceptable deviation limit away from a set point gain.
    Type: Grant
    Filed: March 28, 2002
    Date of Patent: February 3, 2004
    Assignee: Nortel Networks Limited
    Inventors: Roger D Griggs, Barrie Flintham
  • Publication number: 20030194374
    Abstract: Compositions and method including a visual marker for monitoring patient compliance with a medication regimen. The marker is formulated with a rapid dissolve layer and adhered to, or ingested with, an orally administrable medicament. Upon ingestion, the marker is released causing a detectable marker-induced property in the oral and/or pharyngeal cavity of a subject. By examining the patient's oral and/or pharyngeal cavity and articles associated with the patient, one can determine whether the medicament has been ingested based upon the presence or absence of the property. The composition is also useful for tracking the location of an un-ingested medicament.
    Type: Application
    Filed: March 26, 2003
    Publication date: October 16, 2003
    Applicant: Xanodyne Pharmacal, Inc.
    Inventors: Ralph A. Heasley, Gilbert R. Gonzales, Roger D. Griggs
  • Publication number: 20020196531
    Abstract: An amplifying module 101 for an optical network has a fiber amplifier 102 for amplifying a multiplexed optical stream having a plurality of wavelength channels. The fiber amplifier 102 has a set point gain. The module 101 has module control means 108 for controlling the operating conditions of the fiber amplifier 102 and supplying means for supplying to the module control means 108 information representative of the channel loading condition. In response to the information, the module control means 108 adjusts the operating conditions of the fiber amplifier 102 such that the fiber amplifier gain does not exceed an acceptable deviation limit away from a set point gain.
    Type: Application
    Filed: March 28, 2002
    Publication date: December 26, 2002
    Inventors: Roger D. Griggs, Barrie Flintham
  • Publication number: 20020095072
    Abstract: A method and combination including a visual marker for monitoring a patient to determine compliance with a medication regimen. An orally administrable medication composition is provided in combination with a visual marker. When the combination is orally ingested, the marker causes a coloration or discoloration of the oral and/or pharyngeal cavity of a subject. By visually observing the oral and/or pharyngeal cavity of the subject, one can determine whether medication has been ingested based upon the presence or absence of the coloration/discoloration.
    Type: Application
    Filed: January 17, 2001
    Publication date: July 18, 2002
    Applicant: Drug Enhancement Company of America, LLC
    Inventors: Gilbert R. Gonzales, Roger D. Griggs